SPARTA COMMERCIAL SERVICES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SPARTA COMMERCIAL SERVICES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Apr 30, 2012 | $601.8K | Aug 14, 2012 |
| FY2012 | Apr 30, 2011 | $513.8K | Aug 14, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $235.5K | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $192.0K | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $256.9K | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | $245.5K | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | $259.7K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $320.8K | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | $384.7K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $446.2K | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | $547.7K | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | $635.9K | Jul 9, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $207.4K | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $155.3K | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $213.9K | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | $194.9K | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | $198.7K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $260.5K | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | $355.1K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $402.9K | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | $498.2K | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | $524.7K | Jul 9, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($2.11M) | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | ($607.3K) | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $1.02M | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | ($2.20M) | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | ($2.28M) | Aug 15, 2022 |
| FY2020 | Apr 30, 2020 | ($787.2K) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($1.69M) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($2.84M) | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | ($2.60M) | Jul 9, 2020 |
| FY2016 | Apr 30, 2016 | ($5.58M) | Aug 26, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($1.23M) | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | ($864.5K) | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($1.39M) | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | ($1.67M) | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | ($1.20M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($792.0K) | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | ($847.0K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($842.4K) | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | ($984.6K) | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | ($2.16M) | Jul 9, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Apr 30, 2022 | $217.1K | Aug 15, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($1.23M) | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | ($1.21M) | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($3.08M) | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | ($2.07M) | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | ($678.4K) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($626.8K) | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | ($759.0K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($657.8K) | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | ($647.2K) | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | ($1.68M) | Jul 9, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Apr 30, 2016 | $0 | Aug 26, 2016 |
| FY2016 | Apr 30, 2015 | $3.9K | Aug 26, 2016 |
| FY2015 | Apr 30, 2014 | $0 | Aug 13, 2015 |
| FY2013 | Apr 30, 2013 | $0 | Aug 13, 2013 |
| FY2013 | Apr 30, 2012 | $8.1K | Aug 13, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $756.6K | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $119.7K | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $13.0K | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | $9.3K | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | $33.3K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $43.8K | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | $33.6K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $25.4K | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | $100.5K | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | $137.7K | Jul 9, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $11.35M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $9.76M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $10.26M | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | $12.96M | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | $12.66M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $11.64M | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | $12.05M | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $11.96M | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | $10.22M | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | $8.23M | Jul 9, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($11.61M) | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | ($10.64M) | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($11.22M) | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | ($13.93M) | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | ($13.61M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($12.57M) | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | ($12.98M) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($12.88M) | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | ($11.03M) | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | ($8.84M) | Jul 9, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Apr 30, 2016 | $0 | Aug 26, 2016 |
| FY2016 | Apr 30, 2015 | $10.0K | Aug 26, 2016 |
| FY2015 | Apr 30, 2014 | $10.0K | Aug 13, 2015 |
| FY2014 | Apr 30, 2013 | $10.0K | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | $10.0K | Aug 13, 2013 |
| FY2012 | Apr 30, 2011 | $10.0K | Aug 14, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($68.92M) | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | ($66.80M) | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($66.15M) | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | ($67.18M) | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | ($64.99M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($62.70M) | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | ($61.92M) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($60.23M) | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | ($57.39M) | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | ($54.76M) | Jul 9, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $131.0K | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $101.0K | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $4.0K | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | $317 | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | $396 | Aug 15, 2022 |
| FY2020 | Apr 30, 2019 | $13 | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $998 | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | $2.6K | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | $33.7K | Jul 9, 2020 |
| FY2016 | Apr 30, 2015 | $14.0K | Aug 26, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $8.37M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $7.17M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $5.10M | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | $4.68M | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | $4.68M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $4.93M | Aug 16, 2021 |
| FY2020 | Apr 30, 2019 | $4.11M | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $4.46M | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | $4.26M | Jul 9, 2020 |
| FY2017 | Apr 30, 2016 | $3.49M | Jul 9, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | 0 | Aug 15, 2022 |
| FY2015 | Apr 30, 2015 | 0 | Aug 13, 2015 |
| FY2015 | Apr 30, 2014 | 0 | Aug 13, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Aug 18, 2023 |
| FY2015 | Apr 30, 2015 | 0 | Aug 13, 2015 |
| FY2015 | Apr 30, 2014 | 0 | Aug 13, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 40.13M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | 29.50M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | 23.05M | Aug 14, 2024 |
| FY2023 | Apr 30, 2022 | 15.13M | Aug 18, 2023 |
| FY2022 | Apr 30, 2021 | 9.81M | Aug 15, 2022 |
| FY2025 | Jul 30, 2020 | 7.03M | Aug 13, 2025 |
| FY2021 | Apr 30, 2020 | 9.43M | Aug 16, 2021 |
| FY2021 | Apr 30, 2019 | 627.09M | Aug 16, 2021 |
| FY2019 | Apr 30, 2018 | 620.86M | Jul 9, 2020 |
| FY2018 | Apr 30, 2017 | 583.27M | Jul 9, 2020 |